Jin Medical International Ltd. (ZJYL)
USD 0.61
(-4.21%)
USD 0.61
(-4.21%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.05 Million USD | -24.85% |
| 2022 | 6.72 Million USD | -2.44% |
| 2021 | 6.89 Million USD | -1.3% |
| 2020 | 6.98 Million USD | 21.76% |
| 2019 | 5.73 Million USD | -5.36% |
| 2018 | 6.06 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 6.36 Million USD | 26.02% |
| 2024 Q2 | 6.36 Million USD | 0.0% |
| 2023 Q4 | 5.05 Million USD | -13.72% |
| 2023 Q2 | 6.5 Million USD | -1.35% |
| 2023 Q3 | 5.85 Million USD | -10.02% |
| 2023 FY | 5.05 Million USD | -24.85% |
| 2023 Q1 | 6.59 Million USD | -1.87% |
| 2022 Q2 | 7.94 Million USD | -2.67% |
| 2022 FY | 6.72 Million USD | -2.44% |
| 2022 Q4 | 6.72 Million USD | -2.27% |
| 2022 Q3 | 6.88 Million USD | -13.38% |
| 2022 Q1 | 8.16 Million USD | 18.41% |
| 2021 Q2 | 8.8 Million USD | 0.0% |
| 2021 FY | 6.89 Million USD | -1.3% |
| 2021 Q3 | 7.04 Million USD | -20.07% |
| 2021 Q1 | 8.8 Million USD | 21.46% |
| 2021 Q4 | 6.89 Million USD | -2.11% |
| 2020 Q2 | 8.23 Million USD | 0.0% |
| 2020 Q1 | 8.23 Million USD | 43.6% |
| 2020 FY | 6.98 Million USD | 21.76% |
| 2020 Q4 | 7.25 Million USD | 0.0% |
| 2020 Q3 | 7.25 Million USD | -11.94% |
| 2019 Q4 | 5.73 Million USD | 0.0% |
| 2019 Q3 | 5.73 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 5.73 Million USD | -5.36% |
| 2018 FY | 6.06 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 71.734% |
| AngioDynamics, Inc. | 60.61 Million USD | 91.664% |
| AtriCure, Inc. | 67.89 Million USD | 92.558% |
| Avinger, Inc. | 5.29 Million USD | 4.622% |
| Azenta, Inc. | 128.19 Million USD | 96.058% |
| BioLife Solutions, Inc. | 43.45 Million USD | 88.372% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.313% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -0.062% |
| Femasys Inc. | 667.11 Thousand USD | -657.458% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 79.555% |
| Hologic, Inc. | 679.8 Million USD | 99.257% |
| ICU Medical, Inc. | 709.36 Million USD | 99.288% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.586% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -45.151% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 90.344% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -489.797% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -489.797% |
| Masimo Corporation | 545 Million USD | 99.073% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -212.457% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 98.337% |
| Nephros, Inc. | 2.47 Million USD | -104.58% |
| NovoCure Limited | 38.15 Million USD | 86.755% |
| NEXGEL, Inc. | 1.31 Million USD | -283.104% |
| NEXGEL, Inc. | 1.31 Million USD | -283.104% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 62.768% |
| OraSure Technologies, Inc. | 47.61 Million USD | 89.387% |
| Pro-Dex, Inc. | 15.26 Million USD | 66.906% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -922.128% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -76.184% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.125% |
| Repligen Corporation | 202.32 Million USD | 97.502% |
| Sanara MedTech Inc. | 4.71 Million USD | -7.114% |
| STAAR Surgical Company | 35.13 Million USD | 85.616% |
| Sharps Technology, Inc. | 1.7 Million USD | -195.655% |
| Utah Medical Products, Inc. | 9.58 Million USD | 47.264% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.19% |